Glyxambi (empagliflozin and linagliptin) Tablets 25 mg/5 mg 30 tablets Rx only NDC 0597-0164-30 Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877 USA

Recall Number: D-0455-2021

Firm: Cardinal Health Inc.

Classification: Class II

Status: Terminated

Report Date: 20210602

Initiation Date: 20210315

Termination Date: 20240617

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Glyxambi (empagliflozin and linagliptin) Tablets 25 mg/5 mg 30 tablets Rx only NDC 0597-0164-30 Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877 USA